Marker Driven Selection of Patients for Prostate Biopsy and Management

Active, not recruitingOBSERVATIONAL
Enrollment

289

Participants

Timeline

Start Date

June 29, 2020

Primary Completion Date

June 1, 2027

Study Completion Date

June 1, 2027

Conditions
PSAElevated PSAProstate Cancer
Trial Locations (1)

33136

University of Miami, Miami

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

University of Miami

OTHER